onshow, you must be drinking too much champagne ;)
I can't agree with you saying $5-10m revs justifies a "shar price of 20cents plus which doesn't include the future potential of further signings." especially the second bit seems off
Let's assume $5-$10m comes at zero cost of sales Current expenses are ~$700k/qtr, so $2.8m p.a. Which would leave $2.2-7.2m potential profits remaining out of that suggested $5-10m revenues Less tax circa 30% say, gives $1.5m - 5m NPAT
put even a high growth PE of 20 on those numbers you get a market cap of $30m-$100m and with 762m ords on issue that's 3.9cps - 13cps
So... we are ALREADY pricing in an anticipated $7m or so in revs and upside solely comes from the expectation of further signings
no offense meant, just telling it as i see it - enjoy your posts
this baby's upside is from anticipated revs in the tens of million; signing one research and one IVD contract would tend to suggest that's coming, and some.
ADO Price at posting:
8.1¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)